Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000992522 | SCV001144908 | uncertain significance | not provided | 2019-05-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002549797 | SCV003522045 | uncertain significance | Peroxisome biogenesis disorder | 2022-02-09 | criteria provided, single submitter | clinical testing | This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 783 of the PEX6 protein (p.Glu783Lys). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with PEX6-related conditions. ClinVar contains an entry for this variant (Variation ID: 805119). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV001827135 | SCV002077283 | uncertain significance | Zellweger spectrum disorders | 2020-08-12 | no assertion criteria provided | clinical testing |